The G Protein Coupled Receptors Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Cell Lines, Detection Kits, Cell Culture Reagents, Ligands), By Assay Type (cAMP Functional Assays, Calcium Functional Assays, β-Arrestin Functional Assays, Radioligand Binding and GTPγS Functional Assays, Internalization Assays, Trafficking Assays, Others), By Application (Cancer Research, CNS Research, Metabolic Research, Cardiovascular Research, Inflammation Research, Respiratory Research, Others).
The G protein-coupled receptors (GPCRs) market in 2024 serves the demand for pharmaceutical research tools, drug discovery platforms, and therapeutic targets related to GPCR signaling pathways and receptor-mediated pharmacology, playing critical roles in cellular signaling, physiological regulation, and drug action across various therapeutic areas, including neuroscience, cardiovascular disease, metabolic disorders, and oncology. GPCRs are a large family of cell surface receptors involved in transducing extracellular signals into intracellular responses through G protein-mediated signaling cascades, cyclic AMP (cAMP) signaling pathways, and downstream effector molecules, modulating neurotransmission, hormone secretion, immune responses, and cellular proliferation. Market dynamics are driven by factors such as the increasing understanding of GPCR biology and structure-function relationships, the growing interest in GPCR-targeted drug discovery and development, and advancements in GPCR screening assays, structural biology, and computational modeling for rational drug design and structure-based drug optimization. Collaboration between GPCR research institutions, pharmaceutical companies, and academic laboratories drives innovation and market expansion in GPCR drug discovery, supporting more efficient lead identification, lead optimization, and drug candidate development for novel therapeutics targeting GPCR pathways and signaling networks.
A significant trend in the G Protein-Coupled Receptors (GPCRs) market is the growing emphasis on drug discovery efforts targeting these receptors. GPCRs are integral membrane proteins involved in various physiological processes and are attractive targets for pharmaceutical intervention. With advancements in understanding GPCR signaling pathways and their roles in disease pathogenesis, there is a surge in research and development activities aimed at discovering novel therapeutics that modulate GPCR activity. This trend is fueled by the recognition of GPCRs as key regulators of cellular signaling and the potential of GPCR-targeted drugs in addressing a wide range of diseases, including neurological disorders, cardiovascular conditions, and cancer.
A primary driver in the G Protein-Coupled Receptors (GPCRs) market is the high therapeutic potential of GPCR-targeted drugs and the abundant opportunities for drug development. GPCRs are involved in the regulation of numerous physiological processes and are implicated in the pathogenesis of various diseases. As a result, pharmaceutical companies and research institutions are actively pursuing drug discovery programs focused on GPCRs to address unmet medical needs and develop innovative treatments. The diversity of GPCR subtypes and their widespread distribution in tissues offer a rich landscape for drug discovery, with the potential to generate a pipeline of novel therapeutics addressing a spectrum of diseases and conditions.
An opportunity for market growth in the G Protein-Coupled Receptors (GPCRs) market lies in the advancements in structural biology and rational drug design techniques to facilitate the development of GPCR-targeted drugs. Structural elucidation of GPCR-ligand complexes through techniques such as X-ray crystallography, cryo-electron microscopy, and nuclear magnetic resonance spectroscopy has provided invaluable insights into GPCR structure-function relationships and ligand binding modes. These structural insights enable the rational design of small molecules and biologics with improved selectivity, potency, and pharmacokinetic properties, leading to the development of next-generation GPCR therapeutics. By leveraging advances in structural biology and computational modeling, pharmaceutical companies and research institutions can accelerate the discovery and optimization of GPCR-targeted drugs, unlocking new treatment modalities for various diseases and driving innovation in the pharmaceutical industry.
By Product
Cell Lines
Detection Kits
Cell Culture Reagents
Ligands
By Assay Type
cAMP Functional Assays
Calcium Functional Assays
β-Arrestin Functional Assays
Radioligand Binding and GTPγS Functional Assays
Internalization Assays
Trafficking Assays
Others
By Application
Cancer Research
CNS Research
Metabolic Research
Cardiovascular Research
Inflammation Research
Respiratory Research
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Abcam plc
Addex Therapeutics
Becton, Dickinson and Company
BioInvenu Inc
Danaher (Molecular Devices LLC)
Enzo Biochem Inc (Enzo Life Sciences Inc)
Eurofins Scientific
HD Biosciences Co. Ltd
Merck KGaA
PerkinElmer Inc
Promega Corp
Thermo Fisher Scientific
*- List Not Exhaustive
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the G Protein Coupled Receptors Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the G Protein Coupled Receptors Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 G Protein Coupled Receptors Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global G Protein Coupled Receptors Market Size Outlook, $ Million, 2021 to 2030
3.2 G Protein Coupled Receptors Market Outlook by Type, $ Million, 2021 to 2030
3.3 G Protein Coupled Receptors Market Outlook by Product, $ Million, 2021 to 2030
3.4 G Protein Coupled Receptors Market Outlook by Application, $ Million, 2021 to 2030
3.5 G Protein Coupled Receptors Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of G Protein Coupled Receptors Market Industry
4.2 Key Market Trends in G Protein Coupled Receptors Market Industry
4.3 Potential Opportunities in G Protein Coupled Receptors Market Industry
4.4 Key Challenges in G Protein Coupled Receptors Market Industry
5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global G Protein Coupled Receptors Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global G Protein Coupled Receptors Market Outlook By Segments
7.1 G Protein Coupled Receptors Market Outlook by Segments
By Product
Cell Lines
Detection Kits
Cell Culture Reagents
Ligands
By Assay Type
cAMP Functional Assays
Calcium Functional Assays
β-Arrestin Functional Assays
Radioligand Binding and GTPγS Functional Assays
Internalization Assays
Trafficking Assays
Others
By Application
Cancer Research
CNS Research
Metabolic Research
Cardiovascular Research
Inflammation Research
Respiratory Research
Others
8 North America G Protein Coupled Receptors Market Analysis And Outlook To 2030
8.1 Introduction to North America G Protein Coupled Receptors Markets in 2024
8.2 North America G Protein Coupled Receptors Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America G Protein Coupled Receptors Market size Outlook by Segments, 2021-2030
By Product
Cell Lines
Detection Kits
Cell Culture Reagents
Ligands
By Assay Type
cAMP Functional Assays
Calcium Functional Assays
β-Arrestin Functional Assays
Radioligand Binding and GTPγS Functional Assays
Internalization Assays
Trafficking Assays
Others
By Application
Cancer Research
CNS Research
Metabolic Research
Cardiovascular Research
Inflammation Research
Respiratory Research
Others
9 Europe G Protein Coupled Receptors Market Analysis And Outlook To 2030
9.1 Introduction to Europe G Protein Coupled Receptors Markets in 2024
9.2 Europe G Protein Coupled Receptors Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe G Protein Coupled Receptors Market Size Outlook By Segments, 2021-2030
By Product
Cell Lines
Detection Kits
Cell Culture Reagents
Ligands
By Assay Type
cAMP Functional Assays
Calcium Functional Assays
β-Arrestin Functional Assays
Radioligand Binding and GTPγS Functional Assays
Internalization Assays
Trafficking Assays
Others
By Application
Cancer Research
CNS Research
Metabolic Research
Cardiovascular Research
Inflammation Research
Respiratory Research
Others
10 Asia Pacific G Protein Coupled Receptors Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific G Protein Coupled Receptors Markets in 2024
10.2 Asia Pacific G Protein Coupled Receptors Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific G Protein Coupled Receptors Market size Outlook by Segments, 2021-2030
By Product
Cell Lines
Detection Kits
Cell Culture Reagents
Ligands
By Assay Type
cAMP Functional Assays
Calcium Functional Assays
β-Arrestin Functional Assays
Radioligand Binding and GTPγS Functional Assays
Internalization Assays
Trafficking Assays
Others
By Application
Cancer Research
CNS Research
Metabolic Research
Cardiovascular Research
Inflammation Research
Respiratory Research
Others
11 South America G Protein Coupled Receptors Market Analysis And Outlook To 2030
11.1 Introduction to South America G Protein Coupled Receptors Markets in 2024
11.2 South America G Protein Coupled Receptors Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America G Protein Coupled Receptors Market size Outlook by Segments, 2021-2030
By Product
Cell Lines
Detection Kits
Cell Culture Reagents
Ligands
By Assay Type
cAMP Functional Assays
Calcium Functional Assays
β-Arrestin Functional Assays
Radioligand Binding and GTPγS Functional Assays
Internalization Assays
Trafficking Assays
Others
By Application
Cancer Research
CNS Research
Metabolic Research
Cardiovascular Research
Inflammation Research
Respiratory Research
Others
12 Middle East And Africa G Protein Coupled Receptors Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa G Protein Coupled Receptors Markets in 2024
12.2 Middle East and Africa G Protein Coupled Receptors Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa G Protein Coupled Receptors Market size Outlook by Segments, 2021-2030
By Product
Cell Lines
Detection Kits
Cell Culture Reagents
Ligands
By Assay Type
cAMP Functional Assays
Calcium Functional Assays
β-Arrestin Functional Assays
Radioligand Binding and GTPγS Functional Assays
Internalization Assays
Trafficking Assays
Others
By Application
Cancer Research
CNS Research
Metabolic Research
Cardiovascular Research
Inflammation Research
Respiratory Research
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abcam plc
Addex Therapeutics
Becton, Dickinson and Company
BioInvenu Inc
Danaher (Molecular Devices LLC)
Enzo Biochem Inc (Enzo Life Sciences Inc)
Eurofins Scientific
HD Biosciences Co. Ltd
Merck KGaA
PerkinElmer Inc
Promega Corp
Thermo Fisher Scientific
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Product
Cell Lines
Detection Kits
Cell Culture Reagents
Ligands
By Assay Type
cAMP Functional Assays
Calcium Functional Assays
β-Arrestin Functional Assays
Radioligand Binding and GTPγS Functional Assays
Internalization Assays
Trafficking Assays
Others
By Application
Cancer Research
CNS Research
Metabolic Research
Cardiovascular Research
Inflammation Research
Respiratory Research
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
The global G Protein Coupled Receptors Market is one of the lucrative growth markets, poised to register a 5.6% growth (CAGR) between 2024 and 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Abcam plc, Addex Therapeutics, Becton, Dickinson and Company, BioInvenu Inc, Danaher (Molecular Devices LLC), Enzo Biochem Inc (Enzo Life Sciences Inc), Eurofins Scientific, HD Biosciences Co. Ltd, Merck KGaA, PerkinElmer Inc, Promega Corp, Thermo Fisher Scientific
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume